Subsequently to the publication of the above article, the authors have found that Fig. 4A on p. 1532 contained some errors. Owing to mistakes made during the preparation and revision of the manuscript, the invasion assay data images selected to show both the 'Control' and 'shRNA2' groups of the invasion and migration experiments were derived from the same original sources. A corrected version of the Fig. 4, showing the correct data for the invasion and migration assay experiments with the Control and shRNA2 groups, is shown below. These inadvertent errors did not affect the conclusions reported in this paper, and all the authors agree with this Corrigendum. The authors thank the editor of Oncology Reports for presenting them with the opportunity to publish this Corrigendum, and apologize to the editor and to the readership of the journal for any inconvenience caused. [the original article was published in Oncology Reports 42: 1527-1538, 2019; DOI: 10.3892/or.2019.7257].

中文翻译：

---

[更正] Linc01105 在神经母细胞瘤的发展中充当致癌基因。

在上述文章发表后，作者发现第 4 页的图 4A。1532 包含一些错误。由于在手稿的准备和修订过程中犯了错误，选择显示入侵和迁移实验的“控制”和“shRNA2”组的入侵检测数据来自相同的原始来源。图 4 的修正版本显示了对照和 shRNA2 组的侵袭和迁移测定的正确数据，如下所示。这些无意的错误并未影响本文报告的结论，所有作者均同意本勘误表。作者感谢Oncology Reports的编辑为他们提供发表此勘误的机会，并就由此造成的任何不便向编辑和期刊读者表示歉意。【原文发表于 Oncology Reports 42: 1527-1538, 2019；DOI：10.3892/或.2019.7257]。